Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

Research output: Contribution to journalJournal articleResearchpeer-review

Emilie S. Andersen, A. Lund, J. I. Bagger, C Andreasen, MF Grøndahl, Carolyn F. Deacon, Bolette Hartmann, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll Lauritsen

Original languageEnglish
JournalDiabetes, Obesity and Metabolism
Issue number8
Pages (from-to)1937-1943
Publication statusPublished - Aug 2018

ID: 195511796